Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014;106(5):dju078.

Article  PubMed  PubMed Central  Google Scholar 

Bond-Smith D, Stone J. Methodological challenges and updated findings from a meta-analysis of the association between mammographic density and breast cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(1):22–31.

Article  CAS  PubMed  Google Scholar 

McCarthy AM, Ehsan S, Appel S, Welch M, He W, Bahl M, et al. Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram. Cancer. 2021;127(18):3334–42.

Article  CAS  PubMed  Google Scholar 

Bodewes FTH, van Asselt AA, Dorrius MD, Greuter MJW, de Bock GH. Mammographic breast density and the risk of breast cancer: a systematic review and meta-analysis. Breast. 2022;66:62–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Britton P, Warwick J, Wallis MG, O’Keeffe S, Taylor K, Sinnatamby R, et al. Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performance. Br J Radiol. 2012;85(1012):415–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weigel S, Heindel W, Heidrich J, Hense HW, Heidinger O. Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol. 2017;27(7):2744–51.

Article  PubMed  Google Scholar 

D’Orsi CJ, Sickles, EA, Mendelson, EB, Morris, EA, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, Virginia: American College of Radiology; 2013.

Mann RM, Athanasiou A, Baltzer PAT, Camps-Herrero J, Clauser P, Fallenberg EM, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022;32(6):4036–45.

Article  PubMed  PubMed Central  Google Scholar 

Monticciolo DL, Newell MS, Moy L, Lee CS, Destounis SV. Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR. J Am Coll Radiol. 2023;20:902–14.

Article  PubMed  Google Scholar 

Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014;106(10):dju255.

Article  PubMed  PubMed Central  Google Scholar 

McCarthy AM, Keller BM, Pantalone LM, Hsieh MK, Synnestvedt M, Conant EF, et al. Racial differences in quantitative measures of area and volumetric breast density. J Natl Cancer Inst. 2016;108(10):djw104.

Article  PubMed  PubMed Central  Google Scholar 

Kerlikowske K, Bissell MCS, Sprague BL, Tice JA, Tossas KY, Bowles EJA, et al. Impact of BMI on prevalence of dense breasts by race and ethnicity. Cancer Epidemiol Biomarkers Prev. 2023;32(11):1524–30.

Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, et al. Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA. 2020;323(8):746–56.

Article  PubMed  PubMed Central  Google Scholar 

Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med. 2019;381(22):2091–102.

Article  PubMed  Google Scholar 

Weinstein SP, Korhonen K, Cirelli C, Schnall MD, McDonald ES, Pantel AR, et al. Abbreviated breast magnetic resonance imaging for supplemental screening of women with dense breasts and average risk. J Clin Oncol. 2020;38(33):3874–82.

Article  PubMed  Google Scholar 

Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology. 2017;283(2):361–70.

Article  PubMed  Google Scholar 

Geuzinge HA, Bakker MF, Heijnsdijk EAM, van Ravesteyn NT, Veldhuis WB, Pijnappel RM, et al. Cost-effectiveness of magnetic resonance imaging screening for women with extremely dense breast tissue. J Natl Cancer Inst. 2021;113(11):1476–83.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Greuter MJW, Vermeulen KM, Brokken FB, Dorrius MD, Lu W, et al. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program. Breast. 2022;61:58–65.

Article  PubMed  Google Scholar 

Mango VL, Goel A, Mema E, Kwak E, Ha R. Breast MRI screening for average-risk women: a Monte Carlo simulation cost-benefit analysis. J Magn Reson Imaging. 2019;49(7):e216–21.

Article  PubMed  PubMed Central  Google Scholar 

Leithner D, Moy L, Morris EA, Marino MA, Helbich TH, Pinker K. Abbreviated MRI of the breast: does it provide value? J Magn Reson Imaging. 2019;49(7):e85–100.

Article  PubMed  Google Scholar 

Pennsylvania General Assembly. 2020 Act 52. 2020. Available from: https://www.legis.state.pa.us/cfdocs/legis/li/uconsCheck.cfm?yr=2020&sessInd=0&act=52.

Pennsylvania General Assembly. 2023 Act 1. 2023. Available from: https://www.legis.state.pa.us/cfdocs/legis/li/uconsCheck.cfm?yr=2023&sessInd=0&act=1.

Hussein H, Abbas E, Keshavarzi S, Fazelzad R, Bukhanov K, Kulkarni S, et al. Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis. Radiology. 2023;306(3):e221785.

Article  PubMed  Google Scholar 

Busch SH, Hoag JR, Aminawung JA, Xu X, Richman IB, Soulos PR, et al. Association of state dense breast notification laws with supplemental testing and cancer detection after screening mammography. Am J Public Health. 2019;109(5):762–7.

Article  PubMed  PubMed Central  Google Scholar 

Aminawung JA, Hoag JR, Kyanko KA, Xu X, Richman IB, Busch SH, et al. Breast cancer supplemental screening: women’s knowledge and utilization in the era of dense breast legislation. Cancer Med. 2020;9(15):5662–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O’Meara ES, Zhu W, et al. Underutilization of supplemental magnetic resonance imaging screening among patients at high breast cancer risk. J Womens Health (Larchmt). 2018;27(6):748–54.

Article  PubMed  Google Scholar 

Lee MV, Aharon S, Kim K, Sunn Konstantinoff K, Appleton CM, Stwalley D, et al. Recent trends in screening breast MRI. J Breast Imaging. 2022;4(1):39–47.

Article  PubMed  Google Scholar 

Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, et al. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016;122(4):611–7.

Article  PubMed  Google Scholar 

Ezratty C, Vang S, Brown J, Margolies LR, Jandorf L, Lin JJ. Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts. Breast Cancer Res Treat. 2020;182(1):181–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott LC, Mobley LR, Kuo TM, Il’yasova D. Update on triple-negative breast cancer disparities for the United States: a population-based study from the United States Cancer Statistics database, 2010 through 2014. Cancer. 2019;125(19):3412–7.

Article  PubMed  Google Scholar 

Prakash O, Hossain F, Danos D, Lassak A, Scribner R, Miele L. Racial disparities in triple negative breast cancer: a review of the role of biologic and non-biologic factors. Front Public Health. 2020;8:576964.

Article  PubMed  PubMed Central  Google Scholar 

Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007;109(9):1721–8.

Article  PubMed  Google Scholar 

Bellio G, Marion R, Giudici F, Kus S, Tonutti M, Zanconati F, et al. Interval breast cancer versus screen-detected cancer: comparison of clinicopathologic characteristics in a single-center analysis. Clin Breast Cancer. 2017;17(7):564–71.

Article  PubMed  Google Scholar 

O’Brien KM, Mooney T, Fitzpatrick P, Sharp L. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis. Breast Cancer Res Treat. 2018;172(1):133–42.

Article  PubMed  Google Scholar 

Brown J, Soukas C, Lin JJ, Margolies L, Santiago-Rivas M, Jandorf L. Physician knowledge, attitudes, and practices regarding breast density. J Womens Health (Larchmt). 2019;28(9):1193–9.

Article  PubMed  Google Scholar 

Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, et al. Travel burden to breast MRI and utilization: are risk and sociodemographics related? J Am Coll Radiol. 2016;13(6):611–9.

Article  PubMed  PubMed Central  Google Scholar 

Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48.

Article  PubMed  Google Scholar 

de Lange SV, Bakker MF, Monninkhof EM, Peeters PHM, de Koekkoek-Doll PK, Mann RM, et al. Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts. Clin Radiol. 2018;73(8):759 e1-e9.

Article  PubMed  Google Scholar 

Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010;254(1):79–87.

Article  PubMed  Google Scholar 

Pan IW, Oeffinger KC, Shih YT. Cost-sharing and out-of-pocket cost for women who received MRI for breast cancer screening. J Natl Cancer Inst. 2022;114(2):254–62.